Biopharma partnering, strategy, and market access in China and APAC
The forum’s content framing centers on what life-sciences leaders need to execute partnerships in China and the wider region, spanning business development strategy, market access considerations, and innovation pipelines across pharma and biotech. The event also positions itself as a place to gain focused insight into what is changing in China and APAC, with program themes commonly linked to regulation, capital and partnering strategy, modality shifts, and the practical execution of cross-border collaborations. In parallel, the agenda structure is designed to support efficient deal conversations by combining conference programming with scheduled one-to-one meetings, so attendees can convert strategic insight into actionable partnering decisions during the same event cycle.